Pharmaceutical Analysis: What effect does particle size have on solubility?
In the pharmaceutical industry, particle size is a key factor since it affects surface area and porosity, which in turn affects a drug’s bioavailability, effectiveness, and shelf life. Particle size is therefore examined in the creation of new active medicinal components as well as in quality control (APIs). In fact, while assessing novel medications, particle size distribution (PSD) is one of the most crucial criteria to look at.
What Does It Mean to Have a Distribution of Particle Size in Pharmaceuticals?
The term “particle size distribution” (PSD) refers to a measurement that is used in the pharmaceutical business to define the range of sizes of particles that are present in a certain medicine. When it comes to the creation of brand-new pharmaceutical goods, the PSD is one of the most crucial evaluation metrics. In most cases, sieve analysis, laser diffraction, dynamic image analysis, or dynamic light scattering are the techniques that are utilised to perform PSD measurements.

Because of their unique forms, the particles in a pharmaceutical product may have varying dimensions at various points. When measuring particles, the diameter is the characteristic that is utilised when the particles are nearly perfect spheres. It’s possible that other kinds of particles, such those with an ovoid or irregular shape, have length and breadth measurements. The most accurate results can be achieved by obtaining horizontal and vertical measurements, although doing so is a more complicated process than just determining a diameter. As a result, the majority of measurements make the assumption that each particle is a spherical, but they only report an estimated diameter. Read More…